General Information
DRACP ID DRACP01990
Peptide Name
Sequence YIWARAERVWLWWGKFLSL
Sequence Length 19
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | EC50=56±3 µM | Not available | Not available | 1 |
Hemolytic Activity Human erythrocytes: Not active up to 400 µM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C125H174N30O24
Absent amino acids CDHMNPQT
Common amino acids W
Mass 280219
Pl 10.45
Basic residues 3
Acidic residues 1
Hydrophobic residues 12
Net charge 2
Boman Index -516
Hydrophobicity 21.05
Aliphatic Index 107.89
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 23490
Absorbance 280nm 1305
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 29679519
Title Designing Anticancer Peptides by Constructive Machine Learning
Year 2018
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_14292